Ragosa Mark 4
4 · Kiniksa Pharmaceuticals International, plc · Filed Dec 10, 2025
Insider Transaction Report
Form 4
Ragosa Mark
CHIEF FINANCIAL OFFICER
Transactions
- Exercise/Conversion
Class A Ordinary Share
2025-12-08$11.10/sh+16,164$179,420→ 47,250 total - Exercise/Conversion
Class A Ordinary Share
2025-12-08$11.97/sh+16,165$193,495→ 63,415 total - Exercise/Conversion
Class A Ordinary Share
2025-12-08$10.76/sh+10,512$113,109→ 73,927 total - Sale
Class A Ordinary Share
2025-12-08$41.49/sh−42,841$1,777,473→ 31,086 total - Exercise/Conversion
Share Option
2025-12-08−16,164→ 5,388 totalExercise: $11.10Exp: 2032-04-06→ Class A Ordinary Share (16,164 underlying) - Exercise/Conversion
Share Option
2025-12-08−16,165→ 12,123 totalExercise: $11.97Exp: 2032-08-31→ Class A Ordinary Share (16,165 underlying) - Exercise/Conversion
Share Option
2025-12-08−10,512→ 14,016 totalExercise: $10.76Exp: 2033-03-31→ Class A Ordinary Share (10,512 underlying)
Footnotes (5)
- [F1]This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on August 14, 2025.
- [F2]This transaction was executed in multiple trades through a broker-dealer at prices ranging between $41.20 and $42.08. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
- [F3]The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is April 7, 2022.
- [F4]The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is September 1, 2022.
- [F5]The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is April 1, 2023.